De Chao Yu
Vermögen: 1 457 Mio $ am 31.08.2026
Vermögen: 1 457 Mio $ am 31.08.2026
De Chao Yu ist Gründer von Innovent Biologics, Inc. und Chengdu Kanghong Pharmaceutical Group Co., Ltd. und bekleidet die Position des Chairman & Chief Executive Officer bei Innovent Biologics, Inc. sowie den Vorsitz der Chinese Antibody Society. Er ist außerdem im Vorstand der Babytree Group und der Cheerwin Group Ltd. und Professor an der Sichuan University. De Chao Yu war zuvor President & Chief Executive Officer bei Chengdu Kanghong Pharmaceutical Group Co., Ltd, Vice President-Research & Development von Applied Genetic Technologies Corp., Vice President-Research & Development bei Applied Genetics, Inc., President & Chief Executive Officer für Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd, Vice President-Research & Development bei Calyon North America, Inc. und Vice President bei Calydon, Inc. sowie Managing Director bei China Medicinal Biotech Association. Er erhielt einen Doktortitel von der Chinesischen Akademie der Wissenschaften.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INNOVENT BIOLOGICS, INC. 6,31 % | 11.05.2026 | 110.058.657 ( 6,31 % ) | 1 457 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Vorstandsvorsitzender | 28.04.2011 |
| DIAN DIAGNOSTICS GROUP CO.,LTD. | Direktor/Vorstandsmitglied | 03.11.2023 |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2008 |
Chinese Antibody Society
Chinese Antibody Society Miscellaneous Commercial ServicesCommercial Services Engages in therapeutic antibodies services | Vorsitzender | 01.01.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
| BABYTREE GROUP | Direktor/Vorstandsmitglied | 10.05.2023 |
| CHEERWIN GROUP LIMITED | Direktor/Vorstandsmitglied | 14.10.2022 |
China Medicinal Biotech Association | Corporate Officer/Principal | 01.01.2019 |
| PHARMABLOCK SCIENCES (NANJING), INC. | Direktor/Vorstandsmitglied | 01.01.2018 |
| CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD | Vorstandsvorsitzender | 01.01.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 15 |
|---|---|
Calydon, Inc.
Calydon, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products for cancer | Health Technology |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calyon North America, Inc.
Calyon North America, Inc. Regional BanksFinance Part of SAS Rue la Boétie, Calyon North America, Inc. is a company based in New York, NY. | Finance |
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells traditional Chinese and biologic drugs | Health Technology |
China Medicinal Biotech Association | |
Dian Diagnostics Group Co. Ltd.
Dian Diagnostics Group Co. Ltd. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
Innovent Biologics, Inc.
Innovent Biologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Applied Genetics, Inc.
Applied Genetics, Inc. Applied Genetics Laboratories, Inc. is a company that specializes in cytogenetic analysis and genomic research for the medical and pharmaceutical industries. The company offers state-of-the-art cytogenetics analysis services, including karyotyping and fluorescence in situ hybridization (Fish) studies, that are tailored to meet the unique needs of their clients while ensuring compliance with FDA Good Laboratory Practice regulations. The company also provides Hybloc™ DNA and normal human metaphase slides for genomic research, contributing to groundbreaking research in medicine, vaccine production, and tissue engineering. The company has been delivering GLP-compliant cytogenomic characterization and species verification for over 30 years and is led by a team of industry experts. The company is based in Brookings, SD. | |
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd.
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
PharmaBlock Sciences (Nanjing), Inc.
PharmaBlock Sciences (Nanjing), Inc. Miscellaneous Commercial ServicesCommercial Services Provides technical services related to the research and development of drug molecular building blocks and process production | Commercial Services |
Babytree Group
Babytree Group Advertising/Marketing ServicesCommercial Services Provides advertising and e-Commerce services | Commercial Services |
Chinese Antibody Society
Chinese Antibody Society Miscellaneous Commercial ServicesCommercial Services Engages in therapeutic antibodies services | Commercial Services |
Cheerwin Group Ltd.
Cheerwin Group Ltd. Chemicals: AgriculturalProcess Industries Develops, manufactures and sells online household & personal care and pet products | Process Industries |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen